URGN
UroGen Pharma (URGN)
$08
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$18.24
Daily low
$17.69
Price at open
$17.69
52 Week High
$30.00
52 Week Low
$3.42
Market cap
859.7M
Dividend yield
0.00%
Volume
54,680
Avg. volume
962,317
P/E ratio
-5.50
UroGen Pharma News
Details
Daily high
$18.24
Daily low
$17.69
Price at open
$17.69
52 Week High
$30.00
52 Week Low
$3.42
Market cap
859.7M
Dividend yield
0.00%
Volume
54,680
Avg. volume
962,317
P/E ratio
-5.50